| Ytd | -25.16% | |
| 1y | -58.90% |
| Open | 0.74 | Prev Close | 0.74 | Low | 0.71 | High | 0.74 | Mkt Cap | 120.83M |
| Vol | 3.22M | Avg Vol | 10.17M | EPS | -0.60 | P/E | -1.20 | Forward P/E | -5.41 |
| Beta | 1.47 | Short Ratio | 6.37 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 0.86 | 200-d Avg | 1.02 | 1yr Est | 13.71 |
HUMA News
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr.,
DURHAM, N.C., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage bi
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.73, signifying a +2.33% move from i
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.63, signifying a -6.44% move from i
– Phase 2a study of CTEV in coronary artery bypass grafting (CABG) is expected to start this quarter
In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.67, marking a +2.22% move from the
Humacyte, Inc. (HUMA) closed at $0.66 in the latest trading session, marking a -1.28% move from the
Humacyte, Inc. (HUMA) closed the most recent trading day at $0.71, moving +2.31% from the previous t
- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
The latest trading day saw Humacyte, Inc. (HUMA) settling at $0.78, representing a -2.32% change fro
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
Humacyte, Inc. (HUMA) closed the most recent trading day at $1.03, moving 3.74% from the previous tr
Humacyte, Inc. (HUMA) Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access
Humacyte, Inc. (HUMA) might move higher on growing optimism about its earnings prospects, which is r
– Positive results from the V012 Phase 3 study were presented at the Society for Vascular Surgery's
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage bi
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage bi
- Humacyte plans to file a supplemental Biologic License Application (BLA) with the Food and Drug Ad
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Roboti
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-q
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
On Thursday, 241 companies hit new 52-week lows.
On Wednesday, 115 stocks hit new 52-week lows.
OnThursday, 137 stocks made new 52-week lows.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings